Anzeige
Mehr »
Freitag, 20.06.2025 - Börsentäglich über 12.000 News
+435 % Beteiligungsrendite durch TAO nach £5 Mio. Finanzierung und Bitcoin-Treasury-Strategie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
319 Leser
Artikel bewerten:
(1)

Vector Consumer Limited Announces Second Acquisition, Dose & Co

LONDON, May 1, 2024 /PRNewswire/ -- Vector Consumer Ltd has taken a significant stride towards expanding its presence in the collagen market with its latest acquisition, Dose & Co. This move swiftly follows another successful acquisition, the Pura Collagen brand. With the global collagen market expected to grow at a 5.8% CAGR reaching $1.03 billion in 2030, it was valued at $630 million in 2021*, it's evident that Vector Consumer has ambitious goals to lead this expanding category.

Dose & Co

Dose & Co is a collagen supplement brand from the ZURU Edge stable. Launched in New Zealand in 2019 by registered nutritionist and naturopath Libby Matthews, Dose & Co's range of premium beauty blends are clinically proven and backed by doctors, dermatologists and aestheticians internationally. With over 4 million tubs sold, 5000+ distribution points globally, countless industry awards, celebrity fans such as Khloe Kardashian, plus praise from almost every major media publication Dose & Co have become a leader in ingestible beauty.

"We are excited by Vector Consumer's shared dedication to unwavering quality and their proven track record of innovating within the Wellness category. Handing over the reins to Vector not only enables the continuation of Dose & Co's mission but also undoubtedly marks a new era of innovation and expansion. We eagerly anticipate witnessing the brand's ongoing evolution and its part in building the future of the ingestible beauty category under Vector's strategic guidance". Paige Harris - General Manager of ZURUs Wellness division.

Liverpool based Vector Consumer was founded by Matt Banks-Crompton and John Pugh in 2019, with a vision to disrupt the global consumer healthcare space. In a short space of time, Vector Consumer has imagined and delivered impactful health and beauty brands capable of leading the global market including SOLV, an award winning female focused supplements brand and the officially licensed Liverpool FC sports and wellness range. With the recent acquisitions of globally renowned brands Pura Collagen and Dose & Co, Vector Consumer is set to become a leading voice in the nutritional collagen industry.

"Over the years Dose & Co has conquered not only markets but hearts across the globe. Its name resonates with consumers worldwide reflecting the remarkable heights it has scaled in the industry. Dose & Co's commitment to quality, innovation and consumer satisfaction has solidified its position as a household name". Matt Banks-Crompton - Managing Director of Vector Consumer.

The Senior Leadership Team at Vector Consumer is led by Managing Director Matt Banks-Crompton. He is joined by Stephen Byrne, Sales Director, Jennifer Mo, Director of Strategy & Implementation and Rob Knowles, Supply Chain & Logistics Director. Vector Consumer will assume all management of the Dose & Co brand from ZURU Edge.

Vector Consumer has an active NPD pipeline and rapid territory expansion plans in place for its current brands, Pura Collagen, SOLV & LFC, with all three launching new products into existing and new accounts across the globe. Dose & Co comes with an impressive NPD pipeline which will see the brand venture into new beauty categories and formats. With the rapid expansion of its brand portfolio Vector Consumer will carefully and thoughtfully engineer the complimentary agencies of each brand. Their goal is to ensure the consumer journey is clear and comprehensive, giving multiple shopper demographics the opportunity to enter the collagen category by goal, price & format.

All image assets and the press release can be downloaded here

www.vectorconsumer.com

*Collagen Peptides Market Size Global Report, 2022 - 2030 (polarismarketresearch.com)

Logo - https://mma.prnewswire.com/media/2402509/Vector_Consumer_Limited_Logo.jpg
Photo - https://mma.prnewswire.com/media/2402510/Matt_Banks_Crompton.jpg
Photo - https://mma.prnewswire.com/media/2402511/Dose_co.jpg

Matt Banks-Crompton, Managing Director of Vector Consumer

Vector_Consumer_Limited_Logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/vector-consumer-limited-announces-second-acquisition-dose--co-302132870.html

© 2024 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.